FAS and Obesity: AMPK activation inhibits downstream targets involved in obesity [37], such as ACC1 and FAS, which are involved in lipogenesis [38], and PPARγ, C/EBPα, and SREBP-1C, which are involved in adipocyte differentiation and lipid accumulation [39].